CO7030963A2 - Nuevos usos pediatricos del cabazitaxel - Google Patents

Nuevos usos pediatricos del cabazitaxel

Info

Publication number
CO7030963A2
CO7030963A2 CO14172855A CO14172855A CO7030963A2 CO 7030963 A2 CO7030963 A2 CO 7030963A2 CO 14172855 A CO14172855 A CO 14172855A CO 14172855 A CO14172855 A CO 14172855A CO 7030963 A2 CO7030963 A2 CO 7030963A2
Authority
CO
Colombia
Prior art keywords
cabazitaxel
pediatric uses
new pediatric
new
see annexes
Prior art date
Application number
CO14172855A
Other languages
English (en)
Inventor
S Sidhu Sukhvinder
Patricia Vrignaud
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of CO7030963A2 publication Critical patent/CO7030963A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)

Abstract

VER ANEXOS
CO14172855A 2012-02-10 2014-08-08 Nuevos usos pediatricos del cabazitaxel CO7030963A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12305151 2012-02-10
EP12306352 2012-10-30

Publications (1)

Publication Number Publication Date
CO7030963A2 true CO7030963A2 (es) 2014-08-21

Family

ID=47714075

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14172855A CO7030963A2 (es) 2012-02-10 2014-08-08 Nuevos usos pediatricos del cabazitaxel

Country Status (21)

Country Link
US (1) US20140350273A1 (es)
EP (1) EP2811996A1 (es)
JP (1) JP2015509929A (es)
KR (1) KR20140129091A (es)
CN (1) CN104334172A (es)
AU (1) AU2013217964A1 (es)
BR (1) BR112014019675A2 (es)
CA (1) CA2864029A1 (es)
CL (1) CL2014002118A1 (es)
CO (1) CO7030963A2 (es)
CR (1) CR20140374A (es)
EA (1) EA201491506A1 (es)
GT (1) GT201400173A (es)
HK (1) HK1199398A1 (es)
IL (1) IL234015A0 (es)
MX (1) MX2014009610A (es)
NZ (1) NZ628565A (es)
PH (1) PH12014501794A1 (es)
SG (1) SG11201404712UA (es)
WO (1) WO2013117683A1 (es)
ZA (1) ZA201405815B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
US20110237540A1 (en) * 2009-11-23 2011-09-29 Crawford Thomas C Cyclodextrin-based polymers for therapeutic delivery

Also Published As

Publication number Publication date
US20140350273A1 (en) 2014-11-27
IL234015A0 (en) 2014-09-30
SG11201404712UA (en) 2014-09-26
KR20140129091A (ko) 2014-11-06
WO2013117683A1 (en) 2013-08-15
JP2015509929A (ja) 2015-04-02
NZ628565A (en) 2016-03-31
HK1199398A1 (en) 2015-07-03
MX2014009610A (es) 2015-09-25
BR112014019675A2 (pt) 2017-07-11
GT201400173A (es) 2015-08-13
EP2811996A1 (en) 2014-12-17
CL2014002118A1 (es) 2015-06-26
AU2013217964A1 (en) 2014-08-28
CN104334172A (zh) 2015-02-04
CR20140374A (es) 2014-12-01
CA2864029A1 (en) 2013-08-15
EA201491506A1 (ru) 2014-12-30
PH12014501794A1 (en) 2014-11-24
ZA201405815B (en) 2015-11-25

Similar Documents

Publication Publication Date Title
SMT201700003B (it) Didropiridoni come inibitori del fattore xia
SMT201700053B (it) Derivato del cicloalcano
CO7151512A2 (es) Inhibidores del nampt
BR112014020543A8 (pt) composições de ração e métodos de utilização das mesmas
CO7170179A2 (es) Moduladores del receptor de estrogeno y sus usos
GB201321123D0 (en) Amplification of circular molecules
BR112015008272A2 (pt) cápsula para preparação de bebidas
UY34601A (es) ?mezclas fungicidas de pirazol?.
FR2997014B1 (fr) Composition sterile dermo-injectable
BR112014026926A2 (pt) uso terapêutico de produtos de semente de chardonnay
CO7020877A2 (es) Anticuerpos anti-asic1 y usos de los mismos
BR112015012907A2 (pt) composição de cuidado pessoal
CO7091179A2 (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CO7151499A2 (es) Formulación inyectable
HK1210238A1 (en) Treatment of fibers for improved dyeability
BR112014018851A2 (pt) melhoramento da estabilidade postural administrando droxidopa
CO7071133A2 (es) Diaminopirimidinas utiles como inhibidores del virus sincicial respiratorio (rsv) humano
GB201102248D0 (en) Treatment of bipolar disorder
DK2916922T3 (da) Behandling af alkalisk bauxitrest
SMT201700072B (it) Utilizzo del pidotimod per il trattamento della psoriasi
ES2739642T8 (es) Balasto y procedimiento de obtención del mismo
BR112014027843A2 (pt) análogos de hexa-depsipeptídeo como compostos anticancerígenos
CO7151534A2 (es) Endoglucanasas con propiedades mejoradas
BR112015024771A2 (pt) cateter
UY34664A (es) Derivados de piridona y piridazinona como antagonistas de mch-1r, composiciones farmacéuticas y sus usos